Empirical Finance, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Empirical Finance, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q2 2021$1,389,0000.0%18,9130.0%0.12%
-51.6%
Q1 2021$1,389,0000.0%18,9130.0%0.24%0.0%
Q4 2020$1,389,000
+33.9%
18,9130.0%0.24%
+9.9%
Q3 2020$1,037,000
-58.4%
18,913
-41.9%
0.22%
-34.9%
Q2 2020$2,494,000
+123.9%
32,549
+78.9%
0.34%
-1.4%
Q1 2020$1,114,000
+30.9%
18,199
+88.1%
0.35%
+67.1%
Q4 2019$851,000
+18.0%
9,676
+1.2%
0.21%
+3.0%
Q3 2019$721,000
-11.8%
9,5610.0%0.20%
-10.3%
Q2 2019$817,000
-20.5%
9,561
+0.5%
0.22%
-14.5%
Q1 2019$1,028,000
-11.8%
9,511
-30.9%
0.26%
-24.3%
Q4 2018$1,166,000
-13.9%
13,7740.0%0.35%
+2.7%
Q3 2018$1,354,000
-15.1%
13,7740.0%0.34%
-16.6%
Q2 2018$1,594,000
-47.0%
13,774
-53.4%
0.40%
+7.2%
Q1 2018$3,006,000
+185.2%
29,545
+193.5%
0.38%
+8.3%
Q4 2017$1,054,000
-54.6%
10,068
-51.1%
0.35%
-56.6%
Q3 2017$2,321,000
+100.4%
20,589
+99.3%
0.80%
+80.0%
Q2 2017$1,158,000
-3.7%
10,332
+0.2%
0.44%
-20.8%
Q1 2017$1,202,000
+3906.7%
10,309
+3555.7%
0.56%
+2710.0%
Q4 2016$30,0002820.02%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders